000			01532 a2200421 4500
005			20250515180212.0
264		0	_c20091231
008			200912s 0 0 eng d
022			_a1520-4804
024	7		_a10.1021/jm9005934 _2doi
040			_aNLM _beng _cNLM
100	1		_aWoodard, Lauren E
245	0	0	_aMalaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose. _h[electronic resource]
260			_bJournal of medicinal chemistry _cDec 2009
300			_a7458-62 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAmides _xchemistry
650	0	4	_aAnimals
650	0	4	_aAntimalarials _xadministration & dosage
650	0	4	_aDimerization
650	0	4	_aDrug Combinations
650	0	4	_aHeterocyclic Compounds _xadministration & dosage
650	0	4	_aMalaria _xdrug therapy
650	0	4	_aMale
650	0	4	_aMefloquine _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
700	1		_aChang, Wonsuk
700	1		_aChen, Xiaochun
700	1		_aLiu, Jun O
700	1		_aShapiro, Theresa A
700	1		_aPosner, Gary H
773	0		_tJournal of medicinal chemistry _gvol. 52 _gno. 23 _gp. 7458-62
856	4	0	_uhttps://doi.org/10.1021/jm9005934 _zAvailable from publisher's website
999			_c19001280 _d19001280